TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
about
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesisGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionNeuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaNTRK gene fusions as novel targets of cancer therapy across multiple tumour typesTRKing down an old oncogene in a new era of targeted therapyRoles for NF-kappaB in nerve cell survival, plasticity, and diseaseNTRK1 fusion in glioblastoma multiformeSmall molecule activators of the Trk receptors for neuroprotectionThe genome sequence of the protostome Daphnia pulex encodes respective orthologues of a neurotrophin, a Trk and a p75NTR: evolution of neurotrophin signaling components and related proteins in the bilateria.The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.Hypoxic tumor microenvironment and cancer cell differentiation.Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status.A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.Hypoxia regulates alternative splicing of HIF and non-HIF target genes.Trk receptor expression and inhibition in neuroblastomasPhase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.Therapeutic targets for neuroblastomas.Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.Clinical significance of NTRK family gene expression in neuroblastomasNovel transcripts reveal a complex structure of the human TRKA gene and imply the presence of multiple protein isoforms.Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.Novel and novel de novo mutations in NTRK1 associated with congenital insensitivity to pain with anhidrosis: a case report.Post-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural HematomaAlternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotypeThe dark side of the NGF family: neurotrophins in neoplasias.SPLOOCE: a new portal for the analysis of human splicing variants.Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells.A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma.Trk kinase inhibitors as new treatments for cancer and pain.On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.Nerve growth factor signaling in prostate health and disease.The connections between neural crest development and neuroblastoma.The molecular profile of microglia under the influence of glioma.Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research.Mechanisms of neuroblastoma regressionRetrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
P2860
1478a0496323b2b5a83775a702a133ce9f18d6b6182c6b1dd58526a62f3a86e848fc4f87b0ff75a92e744ed6f6de46441d4815d1cb0bb193dec9a80744a60f86680412e969ffd112279963d0a4520dcb8fd7555611aa6f9874373ba602efe7a807ac54fdab60f6bb35d3382754bcf253015b386a76155d81b72396d343516ef509fac244866fb0bc553ebaf0ee5d7221b8ab3d76467e632831713eeafa033a02
P248
Q21563389-EECDD78B-B136-4903-86B7-C78EA4978F97Q24568374-17E56DE6-D798-400D-906D-3C99608748A4Q24594695-F0151F7F-8203-4663-BC65-7676721B9037Q28066821-7915B83F-2843-4B7F-B707-E89AF3565889Q28254287-FFB2AC21-B09C-4CE5-981B-C8B1ACEC93C8Q28290234-170A181C-011D-47C2-B313-E8B65FF80C81Q28541127-D87A72CD-8530-451D-B911-2838BFA8E5CBQ33393895-8102AB9F-7A50-4B03-83D6-7115AD309016Q33508938-F26C8B07-B71B-4F85-AFFF-AB963B8706FFQ33643120-5C2491C6-C91E-4655-921F-BB328DD4B983Q33670820-48F66CA6-4638-479F-99B8-3593D0823A91Q33875892-127110EA-272D-47E2-B9B3-77B4451D28C3Q34146619-834B4BE8-CC44-45D0-A958-D9DD999E11D5Q34177914-CA1A1816-4B90-4475-845D-42010AA04CFFQ34549157-3C59E089-08C0-4EDE-9117-EE7F6ED3A994Q34549193-DBFC53AD-8718-400E-BD67-8802A9760E0EQ34560877-E0CE9494-52AA-4A10-83AB-DDBA1E7793BEQ34578418-81D5A9DB-923D-4928-9272-6ABA7E4CD789Q35143965-CEED0A02-CE6F-4697-B619-5FAC1CBB12BCQ35149468-CDF36FD7-ED6B-4378-84CA-D95A16415806Q35673178-FBAE10DF-B11C-4E02-ACA9-44532A4C96CFQ35845700-74491FC2-9BCA-4B7D-A68F-4D2880FB8BA3Q36113481-A4E4B41B-9E9C-4404-846A-4BB54CB8A413Q36151639-450B20E5-8FF9-4A4B-93CC-F162F7F4FE37Q36398266-1333B7B1-9884-4658-BFCC-E6ED63D807EFQ36427681-3F09D7E2-A9CB-4E74-B3BB-B51AA28704F4Q36429595-5D4DC5BE-C42B-4A72-A79D-9DAAB53D6EBAQ36608750-5AF8E94A-F314-4E13-A1D6-6052E306E347Q36654494-4FE9AACF-A1A3-4E46-A7B4-6101770ABE42Q36684601-6F980650-FC61-41BA-A4C7-0882F996553CQ37184905-A648FFAC-70CE-46B2-8B7B-5057F0184CD7Q37396536-DE6E9AA4-23AB-4F53-A5AD-CEB57319B1F4Q37481264-DAA6C5A1-3046-4286-9C06-13358362907BQ37597739-48BE8496-5953-4961-B09A-1A88B5B967BCQ37694590-0DB96DC8-BBB7-4197-8389-4FE55858846BQ37836006-67C5528C-D449-4F1A-A390-E02AADB55BECQ38008966-CF4A1E71-E591-4603-9830-BEDB9530FDC4Q38015343-58A745B5-17ED-467D-B306-CD99EA6EC3A6Q38261519-F9F3C883-51F0-4F09-B3E7-08D18C024C3BQ38262750-0D4305CF-B171-4726-8EA1-67BCBA23A499
P2860
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@ast
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en-gb
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@nl
type
label
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@ast
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en-gb
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@nl
prefLabel
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@ast
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en-gb
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@nl
P2093
P921
P1433
P1476
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma
@en
P2093
Alberto Gulino
Alessandra Tessitore
Andrew R Mackay
Antonella Tacconelli
Antonella Vetuschi
Antonietta R Farina
Beatrice Argenti
Giuseppina Desantis
Isabella Screpanti
Lucia Cappabianca
P304
P356
10.1016/J.CCR.2004.09.011
P407
P577
2004-10-01T00:00:00Z